PHARMACEURICAL FORMULATION HAVING ANTICOAGULATIVE AND ANTIAGGREGATORY ACTION AND METHOD OF PRODUCTION
FIELD: medicine. ^ SUBSTANCE: offered pharmaceutical formulation with anticoagulative and antiaggregatory action contains sodium heparin as reactant and carbomers 940 or 980, trisamine, lavender oil, neroli oil and water as adjuvants taken in specific proportions. Pharmaceutical formulation has gel...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. ^ SUBSTANCE: offered pharmaceutical formulation with anticoagulative and antiaggregatory action contains sodium heparin as reactant and carbomers 940 or 980, trisamine, lavender oil, neroli oil and water as adjuvants taken in specific proportions. Pharmaceutical formulation has gel consistency. Method of production of offered formulation includes sodium heparin aqueous solution, nypagin solution, ethanol solution of lavender and neroli oil, and trisamine sequentially added to water-dispersed carbomers. ^ EFFECT: new formulation is characterised by high pharmaceutical activity; does not have by-effects; stable for keeping; has optimal viscosity and applicable organoleptic property. ^ 4 cl, 1 tbl, 3 ex |
---|